The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.
Maria I. Florez
Advertisement
Articles by Maria I. Florez
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
